Trilostane is a pharmaceutical raw material used in veterinary medicine, primarily for the management of Cushing's syndrome in dogs. It has also been investigated for human conditions such as Cushing's syndrome, Conn's syndrome, and postmenopausal breast cancer.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 13647-35-3
The international HS code for Trilostane (CAS 13647-35-3) is 2937.29.
2937.29
2937 29 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile
KVJXBPDAXMEYOA-CXANFOAXSA-N
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(CC(=C([C@H]4O5)O)C#N)C